期刊文献+

糖痹康对大鼠糖尿病周围神经病变氧化应激影响的实验研究 被引量:2

The influences of Tangbikang on oxidative stress in rats with diabetic peripheral neuropathy
原文传递
导出
摘要 目的 探讨糖痹康对链脲佐菌素(Streptozotocin,STZ)诱导的糖尿病周围神经病变(Diabetic penipheral neuropathy,DPN)大鼠抗氧化作用的影响.方法 腹腔注射STZ 55 mg/kg建立糖尿病大鼠模型,分为正常组,模型组,弥可保组,糖痹康低、中、高剂量组.各组每周测1次体重,8周后处死大鼠,测定血清中血糖(Glu)、超氧化物歧化酶(SOD)、丙二醛(MDA)、一氧化氮合成酶(NOS)、一氧化氮(NO)和糖基化终产物(AGEs)含量及坐骨神经中醛糖还原酶(AR)和Na+-K+-ATP酶活性.结果 坐骨神经组织病理学检查显示,糖痹康组坐骨神经病理学改变较模型组轻.与模型组比较,糖痹康各剂量组大鼠体重第8周差异有统计学意义(P均<0.01);血清SOD、NOS和NO含量增高(P均<0.05),AGEs、MDA含量显著降低(P均<0.01);坐骨神经AR浓度显著降低(P均<0.01),Na+-K+-ATP酶表达显著增加(P均<0.05).结论 糖痹康可改善STZ诱导的DPN过高的氧化应激状态,减轻氧化应激造成的周围神经结构和功能损害,对DPN有一定的神经保护作用. Objective To investigate the influences of Tangbikang on the oxidative stress in rats with diabetic penipheral neuropathy (DPN). Methods Diabetes rats were induced by intraperitoneal injection of STZ, 55 mg/kg and randomly divided into five groups: model group, methycobal treatment group, and Tang Bi Kang low, medium and high dosage treatment group. Body weight was examined every week. All rats were sacrificed at week 8 and the values of blood serum, superoxide dismutase, malondialdehyde, nitric oxide synthase and nitric oxide were detected. Results After treated with Tang Bi Kang, the eighth week's body weight, the levels of SOD, NOS and NO in the blood serum and ATP of sciatic nerve were increased greatly (P<0.01 or P<0.05) and the contents of MDA and AGEs and AR of sciatic nerve were decreased (P<0.01), compared with the model group. Conclusion Tang Bi Kang may lighten the oxidative stress reaction of diabetic penipheral neuropathy and slow down the course of the diabetic penipheral neuropathy.
作者 王佳 刘铜华
出处 《国际中医中药杂志》 2010年第4期296-298,共3页 International Journal of Traditional Chinese Medicine
基金 基金项目:国家科技重大新药创制专项(项目编号:2009ZX09103-303)
关键词 糖尿病周围神经变 糖痹康 STZ 氧化应激 Diabetic peripheral neuropathy Tangbikang Oxidative stress Experimental research
  • 相关文献

参考文献11

二级参考文献79

共引文献40

同被引文献24

  • 1李倩,李宝芬.复荣通脉胶囊主要药效学研究[J].中华中医药杂志,2007,22(5):316-318. 被引量:7
  • 2安淑岩,高占标.益气活血通络汤治疗糖尿病周围神经病变气虚血瘀证临床疗效观察[J].中外健康文摘,2013,9(46):251~251.
  • 3Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China [J]. New England Journal of Medi- cine, 2010, 362(25):1090-101.
  • 4Cakici N, Fakkel T M, Neck J W V, et al. Systematic review of treatments for diabetic peripheral neuropathy [J]. Diabetic Med- icine, 2016. doi:11, 111/dme. 13083.
  • 5Papanas N, Ziegler D. Efficacy of a-lipoic acid in diabetic neu- ropathy. [J]. Expert Opinion on Pharmacotherapy, 2014, 15 (18) ,2721-2731.
  • 6Hotta N, Kawamori R, Atsumi Y, et al. Stratified analyses for selecting appropriate target patients with diabetic peripheral neu- ropathy for long-term treatment with an aldose reductase inhibi- tor, epalrestat [J]. Diabetic Medicine, 2008, 25(7):818-825.
  • 7Greene D, Arezzo JM. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy, Ze- narestat Study Group. [J]. Neurology, 2012, 53(3) :580-591.
  • 8Thornalley PJ. Glycation in diabetic neuropathy: Characteris- tics, consequences, causes, and therapeutic options [J]. Inter- national Review of Neurobiology, 2002, 50 (1) : 37-57.
  • 9张德刚,赵瑛,黄霄群,刘志民,夏培金.褪黑素对糖尿病周围神经病变大鼠氧化应激及周围神经功能和形态的作用[J].中国组织工程研究与临床康复,2008,12(50):9917-9920. 被引量:8
  • 10王佳,刘铜华.糖痹康对糖尿病周围神经病变大鼠坐骨神经传导速度的影响[J].中国中医基础医学杂志,2010,16(3):209-211. 被引量:15

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部